Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe record history now shows a new site revision (v3.4.3) added, replacing the previous revision (v3.4.2).SummaryDifference0.1%

- Check12 days agoChange DetectedNew Study Status and Recruitment Status entries were added, including a Terminated status on 2026-03-03, a 2026-02-27 update (version 16), and a <75% participation indicator. The previous 'Active, not recruiting' status entry was removed (as of 2025-11-21).SummaryDifference0.6%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedNew revision entry Revision: v3.4.2 was added to the history and older notices including Revision: v3.4.1 and a site-wide government funding status notice were removed; these are administrative UI changes and do not affect the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status, with guidance to cc.nih.gov and opm.gov, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedThese changes are limited to UI text and release notes on the Record History page, including a new Show glossary option, color-code explanations for additions and deletions, and the revision label updated to v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedRevision v3.3.4 was added to the Record History and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.